Bioventus Inc.

US$10.61As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BVSHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (2.40%)
Div yield —
ROE 25.78%
Medical Devices
Beta (5Y) 0.62
PE TTM 13.12
TSR TTM 61.98%
Mkt cap US$894.0M
ROIC 11.65%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
16.26%
(72.93%)
Hold 12|10|12|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.30
0.33
0.33
35.83%
42.54%
44.95%
31.42%
Revenue$M
83.61
81.44
82.96
85.96
2.20%
(2.04%)
1.22%
0.78%
Peers (US$894.0M)
Cap (US$)
PE
979.2M
—
853.6M
—
885.0M
40.27x
Capital
TTM
5Y
10Y
Leveragex
0.861
(0.111)
(0.089)
EBIT/Intx
1.398
4.045
3.788
Own earn%
28.36
27.72
27.77
Sh yield%
42.25
29.72
27.21
Owners
Insiders/Inst%
8.50
83.54
Short interest%
4.45
SBC / revenue%
2.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
6–14
$1 testx
0.0
Incr. ROIC%
13